Liver Diseases (NASH and NAFLD)

NASH (Non-alcoholic steatohepatitis) is a liver disease affecting millions of patients worldwide and is a severe progression of the more common NAFLD (Non-Alcoholic Fatty Liver Disease), an excess of fat on the liver. NASH and NAFLD occur in the absence of high alcohol intake, making it different than liver disease caused by excessive alcoholic consumption. It is believed that 20-30% of the general population in Ireland has NAFLD and it is estimated that up to 70% of Type 2 Diabetes patients may also have the disease. Of those patients with NAFLD, it is estimated 20% will develop NASH.

Register your interest below for our Liver Diseases (NASH and NAFLD) study

Thank you for considering participation in GMI’s research. If you choose to fill out the form below, you are agreeing to allow GMI to collect information in order to:

  • Register your interest in the GMI genomics study in NASH and NAFLD
  • Notify you if a GMI study site opens up either in the hospital site and/or GP practice you have indicated
  • Use consultant, hospital site and/or GP practice information to build metrics to help us best understand geographic demand for new study sites
  • Keep you informed of GMI news and new studies if you elect to sign up to receive general news on GMI

All fields with exception of email address are optional.

Genomics Medicine Ireland